# Adele C. Oliva

> Adele C. Oliva is a Series C investor at 1315 Capital backing Health Care. See 3 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Fund: 1315 Capital
- Location: Philadelphia, United States
- Total investments: 3
- Last investment: Sep 2021
- Lead investor: 100%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/in/adelecoliva

Adele C. Oliva is a Series C investor at 1315 Capital in Philadelphia focused on Health Care and Beauty. Adele Oliva is the Founding Partner at 1315 Capital. Adele Oliva attended The Saint Joseph's University.

## Contacts

5 contacts available for Adele C. Oliva: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/adele-c-oliva?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 67% |
| Beauty | 1 | 33% |
| Fashion | 1 | 33% |
| Medical | 1 | 33% |
| Cosmetics | 1 | 33% |

11 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series C | 2 | 67% |
| Post-IPO Equity | 1 | 33% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 2 | 67% |
| New Zealand | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Onkos Surgical | Onkos Surgical is a privately-held surgical oncology company that brings new technology and solutions to surgical oncologists. There are huge opportunities for innovation where the complexity of the disease state requires more diverse solutions. Onkos Surgical will be 100% focused on bringing new technology and solutions to surgical oncologists whoserve a population of which a large portion of the patients are children and the broader population may require personalized solutions. | $33.5M | Series C | Sep 01, 2021 |  |
| Interpace Biosciences | Interpace Biosciences (IDXG) is a dynamic and growing leader in the life sciences industry, providing complex molecular analysis for the early diagnosis and treatment of cancer and supporting the development of targeted therapeutics. Their Interpace Diagnostics business unit provides evidence-based, clinically beneficial molecular diagnostic testsand pathology services, including such widely respected tests as PancraGen®, ThyGeNext®, ThyraMir®, RespriDX® and BarreGen®. | $20M | Post-IPO Equity | Jan 13, 2020 |  |
| Colorescience | Colorescience is a luxury aesthetic makeup line in the medical and resort spa channel, differentiating their products from other makeup lines through high quality, efficacious ingredients, luxury colores and formulations, and convenience and simplicity of use. With every product the company strives to make a difference in the diminution of skincancer and skin conditions. | $15M | Series C | Jul 21, 2017 |  |

3 of 3 investments shown.

## Co-investors
- [Montreux Equity Partners](https://shizune.co/investors/profile/montreaux-equity-partners) — VC Fund, 1 deal together

## About 1315 Capital

VC Fund · Philadelphia, United States

1315 Capital provides expansion and growth capital to commercial-stage specialty pharmaceutical, medical technology, and healthcare services companies, the latter including businesses focused on cost containment and digital health. We believe that these investment areas are attractive largely due to numerous niche market sub-segments and businessmodels where high-quality management teams can rapidly grow small platform companies, in a capital efficient way, into large and important businesses. The firm targets $10-$20 million investments in commercial healthcare entities that have the potential to scale to approximately $100 million of revenue, a highly attractive level for acquisition or to access the public markets.

5 contacts available at 1315 Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Adele C. Oliva | Founding Partner | — |
| Jessica Hou | Partner | — |
| Matthew Reber | Partner | — |
| Brian Schwenk | Chief Financial Officer & Chief Compliance Officer | https://shizune.co/investors/profile/brian-schwenk |
| Craig Matturro | Principal | — |

## Similar investors

### Similar stage
- [Sequoia Capital](https://shizune.co/investors/profile/sequoia-capital) — VC Fund
- [New Enterprise Associates](https://shizune.co/investors/profile/new-enterprise-associates) — VC Fund
- [Bessemer Venture Partners](https://shizune.co/investors/profile/bessemer-venture-partners) — VC Fund

## FAQ

### What does Adele C. Oliva invest in?

Adele C. Oliva invests primarily in Health Care, Beauty and Fashion startups, most often at Series C and Post-IPO Equity stage. Most of the 3 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Adele C. Oliva?

Public channels for Adele C. Oliva include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Adele C. Oliva last invest?

The most recent investment recorded for Adele C. Oliva closed in Sep 2021. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co